Stay updated on GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.

Latest updates to the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedThe page updates to v3.0.2 and removes the MedlinePlus Genetics topic 'Multiple myeloma'; the older revision note (v3.0.1) and the 'Back to Top' element are also removed.SummaryDifference0.1%
- Check9 days agoChange DetectedThe page has been updated with new dates and a revision number, indicating a recent update to the content.SummaryDifference0.4%
- Check16 days agoChange DetectedThe web page has undergone significant updates, including the addition of specific facility names and locations related to plasma cell myeloma, while removing previous location terms and drug information. The revision number has also been updated to v3.0.0.SummaryDifference1%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.0%
- Check45 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference0.3%
Stay in the know with updates to GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.